The U.S. government’s deficit widened to $120 billion in July 2019, fueled by increases in spending on health care and the military, according to data released by the Treasury Department.
2018 was a record year for biotech initial public offerings (IPOs), but 2019 is off to a slow and rocky start because of the government shutdown.
Pfizer announced the company’s succession plan for when Ian Read steps down as chief executive officer on January 1, 2019.
Pfizer announced that the company is planning to sell its current world headquarters building in midtown Manhattan.
In yet another buy in its string of acquisitions, Dublin-based Allergan announced it was acquiring San Francisco-based Tobira Therapeutics.
Now that Pfizer has had two major deals dashed by government resistance, Pfizer CEO Ian Read says he will not be doing any more tax inversions.